SOCS1 and chronic myelogenous leukemia, BCR-ABL1 positive: It should also be noted that SOCS1 overexpression has been reported to subvert IFN-α therapy in chronic myeloid leukemia, therefore, a balance, rather than an excess, of SOCS1 is required for normal cell functioning.